Carregant...
Protective Effect of miR-204 on Doxorubicin-Induced Cardiomyocyte Injury via HMGB1
The toxicity of doxorubicin (DOX) limits its clinical application. Nevertheless, at present, there is no effective drug to prevent DOX-induced cardiac injury. miR-204 is a newly discovered miRNA with many protective effects on cardiovascular diseases. However, little research has been done on the ef...
Guardat en:
| Publicat a: | Oxid Med Cell Longev |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Hindawi
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7695502/ https://ncbi.nlm.nih.gov/pubmed/33274007 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/8819771 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|